Am J Ind Med by Nett, Randall J. et al.
Non-Malignant Respiratory Disease Among Workers in 
Industries Using Styrene—A Review of the Evidence
Randall J. Nett, MD, MPH1,*, Jean M. Cox-Ganser, PhD1, Ann F. Hubbs, DVM, PhD2, Avima 
M. Ruder, PhD3, Kristin J. Cummings, MD, MPH1, Yuh-Chin T. Huang, MD, MHS4, and 
Kathleen Kreiss, MD1
1Respiratory Health Division, Centers for Disease Control and Prevention (CDC), National 
Institute for Occupational Safety and Health (NIOSH), Morgantown, West Virginia
2Health Effects Laboratory Division, National Institute for Occupational Safety and Health 
(NIOSH), CDC, Morgantown, West Virginia
3Division of Surveillance, Hazard Evaluations, and Field Studies, National Institute for 
Occupational Safety and Health (NIOSH), CDC, Cincinnati, Ohio
4Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, 
North Carolina
Abstract
Background—Asthma and obliterative bronchiolitis (OB) cases have occurred among styrene-
exposed workers. We aimed to investigate styrene as a risk factor for non-malignant respiratory 
disease (NMRD).
Methods—From a literature review, we identified case reports and assessed cross-sectional and 
mortality studies for strength of evidence of positive association (i.e., strong, intermediate, 
suggestive, none) between styrene exposure and NMRD-related morbidity and mortality.
Results—We analyzed 55 articles and two unpublished case reports. Ten OB cases and eight 
asthma cases were identified. Six (75%) asthma cases had abnormal styrene inhalation challenges. 
Thirteen (87%) of 15 cross-sectional studies and 12 (50%) of 24 mortality studies provided at least 
suggestive evidence that styrene was associated with NMRD-related morbidity or mortality. Six 
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(66%) of nine mortality studies assessing chronic obstructive pulmonary disease-related mortality 
indicated excess mortality.
Conclusions—Available evidence suggests styrene exposure is a potential risk factor for 
NMRD. Additional studies of styrene-exposed workers are warranted.
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Introduction
Asthma and obliterative bronchiolitis (OB) cases have occurred among workers exposed to 
styrene [Moscato et al., 1987; Cullinan et al., 2013]. OB is a rare and irreversible lung 
disease often associated with exposure to inhalational toxins, and frequently characterized 
by a short latency and insidious onset of dyspnea, non-productive cough, and airway 
obstruction [Epler, 2007; Kreiss, 2013; Barker et al., 2014; Cummings and Kreiss, 2015]. 
We sought to assess the available evidence for the risk of non-malignant respiratory disease 
(NMRD) among workers in industries using styrene.
Styrene (C8H8) is a colorless liquid and volatile organic compound that occurs naturally in 
small quantities in certain plants and foods [Agency for Toxic Substances & Disease 
Registry, 2012]. Commercially produced since the 1920s, styrene is an important industrial 
component used in the manufacturing of reinforced plastics and synthetic rubbers 
[International Agency for Research on Cancer, 2002]. Industries that commonly use styrene 
include boat and automobile manufacturing, plastics, food packaging, wind energy, and 
others [Agency for Toxic Substances & Disease Registry, 2010; Styrene Information & 
Research Center, 2014; McCague et al., 2015]. In 2008, over 12 billion pounds of styrene 
were produced in the United States [Agency for Toxic Substances & Disease Registry, 
2010].
An estimated 90,000 U.S. workers are potentially exposed to styrene [Occupational Safety 
& Health Administration, 2016]. Work-related exposure most commonly occurs through 
inhalation and skin contact [Agency for Toxic Substances & Disease Registry, 2010]. The 
amount of styrene workers are exposed to varies by industry, job, presence of environmental 
controls, and use of personal protective equipment. The Occupational Safety and Health 
Administration (OSHA) permissible exposure limit over an 8-hr time-weighted average 
(TWA) is 100 ppm, the National Institute for Occupational Safety and Health (NIOSH) 
recommended exposure limit is 50 ppm, and the American Conference of Governmental 
Industrial Hygienists (ACGIH) [2015] threshold limit value for an 8-hr TWA is 20 ppm 
[Agency for Toxic Substances & Disease Registry, 2010]. The NIOSH recommended short-
term exposure limit over a 15-min TWA is 100 ppm. The highest levels of occupational 
exposure to styrene have occurred when glass-fiber-reinforced plastics are used in the 
production of automotive parts, bathtubs, boats, and tanks [National Toxicology Program, 
2014]. Occupational exposure to styrene has been associated with deleterious health effects, 
including mucous membrane irritation, changes in color vision, hearing loss, and 
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neurocognitive impairment [Benignus et al., 2005; Agency for Toxic Substances & Disease 
Registry, 2010; Morata et al., 2011]. In addition, the International Agency for Research on 
Cancer [2002] classifies styrene as possibly carcinogenic to humans, and the National 
Toxicology Program [2014] classifies styrene as reasonably anticipated to be a human 
carcinogen.
Styrene toxicology studies support the biological plausibility of styrene-induced NMRD in 
workers. Styrene is a fat-soluble chemical easily absorbed by multiple routes of exposure. 
Consistent with a possible role for styrene exposure and NMRD in workers, the respiratory 
epithelium lining airways is damaged by styrene inhalation at high concentrations and in 
susceptible animal models [Ohashi et al., 1986; Coccini et al., 1997; Cruzan et al., 1997, 
2013]. Detailed information on styrene toxicology is included in recent reviews [National 
Research Council, 2014; National Toxicology Program, 2014].
Materials and Methods
This review was completed using the steps recommended when conducting systematic 
reviews for occupational safety and health questions [Hempel et al., 2016]. Case reports, 
cross-sectional studies, and mortality studies on the respiratory health effects of exposure to 
styrene were identified through searching the published medical literature, reviewing 
relevant bibliographies, identifying manuscripts in the authors' collections, and obtaining 
unpublished data. A PubMed search of the scientific literature published from 1949 through 
October 8, 2015 was conducted.1
An initial collection of 328 citations was retrieved (Fig. 1). Seven duplicates were identified 
and excluded. The collection was then reduced by one author (RJN) to 41 articles by 
scanning titles and abstracts and excluding those not deemed relevant. Additional articles 
were sought from the selected manuscripts' bibliographies (n = 16) and from the authors' 
collections (n = 3), resulting in a total of 60 articles of interest. Five full-text articles were 
reviewed and excluded. Two unpublished case reports made available by two authors (KK, 
YTH) were also included in the analysis, for a total of 57 records of interest. Five relevant 
articles identified by the PubMed search but not in the English language were translated.
Study findings were summarized with respect to styrene exposures, spirometry 
measurements, clinical symptoms or signs, respiratory diagnoses as defined by the original 
study, or mortality from NMRD. Each cross-sectional and mortality study was evaluated by 
two of the authors (RJN, JCG) for evidence of a potential association between styrene 
exposure and development of respiratory symptoms, airflow limitation, NMRD, or NMRD-
related mortality. The evidence for positive association between styrene exposure and 
respiratory morbidity or mortality was characterized as strong, intermediate, or suggestive 
1Search strategy and keywords: [100-42-5.rn. or “benzene, ethenyl-” or “benzene, vinyl-” or “Bulstren K-525-19” or cinnamene or 
ethenylbenzene or “ethylene, phenyl-” or phenethylene or phenylethylene or polystyrene* or stirolo or styreen or styren or styrene* or 
styrol or styrole or styrolene or “styropol SO” or “vinyl benzene” or vinylbenzen or vinylbenzene or vinylbenzol] and [“threshold limit 
value*” or employee* or facilities or facility or industr* or manufactur* or “maximum allowable concentration*” or occupation* or 
worker* or workplace*] and [airway* or alveol* or asthma* or bronch* or (bronchiolit* ADJ oblit*) or chest or exp diagnostic 
techniques, respiratory system/or expiratory or FEV1 or (hypersensit* ADJ pneumon*) or inhal* or laryng* or lung or lungs or 
pneumo* or pulmon* or respirat* or exp respiratory system/or exp respiratory tract diseases/or spiromet*] and [limited to English 
language or (abstracts or structured abstracts)].
Nett et al. Page 3













using a grading rubric developed by three of the authors (RJN, JCG, KK) (Table I). Studies 
with no evidence were characterized as having no association.
Results
Case Reports
In Table II, we summarize 13 articles describing 23 respiratory illness cases and two 
unpublished respiratory illness cases associated with styrene exposure [Moscato et al., 1987, 
1988; Hayes et al., 1991; Shields et al., 1995; Janigan et al., 1997; Occupational Safety and 
Health Research Institute, 2003; Fernandez-Nieto et al., 2006; Volkman et al., 2006; Ye et 
al., 2007; Chen et al., 2013; Cullinan et al., 2013; Lee et al., 2013; Arochena et al., 2014]. 
We reviewed an additional case series by Convery et al. [2001] that was not included in 
Table II or in the below summary analysis. In this case series, five coal miners and one 
automotive repairman who were diagnosed with occupational asthma and had exposure to 
styrene resins had negative inhalation challenges to styrene and were not classified as 
styrene-related cases, suggesting that styrene is not a non-specific trigger of hyperreactive 
airways.
In total, we identified nine OB cases, eight asthma cases, one hypersensitivity pneumonitis 
case, and one eosinophilic bronchitis case among workers exposed to styrene. We also 
included one case of non-occupational OB occurring in a man who burned polystyrene 
insulation and particle board in his home's wood burning stove [Janigan et al., 1997]. In 
addition, Shields et al. [1995] reported four cases of chronic dyspnea following a short-term 
exposure to styrene in a shared confined space. Another respiratory illness case occurred in a 
man who began having attacks of shortness of breath and wheezing 6 months after 
beginning work as a fiberglass painter in a yacht manufacturing plant; he had a severe mixed 
obstructive and restrictive pattern on spirometry (unpublished).
Of the 10 OB cases, the median age was 31.5 years (range: 25–51 years) at clinical 
presentation. The median time from first styrene exposure to respiratory symptom onset was 
9.5 months (range: 4 hr–4 years), consistent with a short-latency disease. Only three cases 
were current smokers. Six cases occurred among workers in the boat manufacturing 
industry. One case occurred in a man after he assumed the job of another worker who had 
been diagnosed with OB and left his job following a lung transplant [Cullinan et al., 2013]. 
Five cases were known to have been diagnosed following pathologic analyses of open 
biopsy (n = 4) and explanted tissue (n = 1) specimens, and five cases were diagnosed based 
upon clinical findings. Two cases received lung transplants and two cases died (one from 
complications of a heart and lung transplant, and one from respiratory failure).
Of the eight asthma cases, the median age was 40 years (range: 30–50 years) at clinical 
presentation. Of the six cases with known time from first styrene exposure to respiratory 
symptom onset, the median time was 4 years (range: 1 month–20 years). Two cases occurred 
among workers in the automotive repair industry. Six cases had abnormal inhalational 
challenges to styrene. Of the six cases with known outcomes, five had improved or resolved 
symptoms after changing jobs and one died of respiratory failure after developing an acute 
asthma exacerbation within 2 hr of leaving work.
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The four respiratory illness cases described by Shields et al. [1995] occurred among workers 
not previously exposed to styrene, following 3 months of working in a confined space with 
exposures to high styrene concentrations that led to neurotoxic effects, and without adequate 
respiratory protection. One of these cases occurred in a 23-year-old male who began having 
respiratory symptoms within 1 day of exposure. Worsening cough and respiratory symptoms 
led to his dismissal within 3 months of beginning his job. Two weeks after leaving his job he 
was hospitalized for pneumonia and developed acute respiratory distress syndrome. Six 
years after exposure, he had a forced vital capacity (FVC) of 61% of predicted, indicating 
chronic airways disease. He and the other three exposed workers suffered chronic dyspnea 
several years after the initial exposure, consistent with OB or other short-latency and 
irreversible NMRD.
Cross-Sectional Studies
In Table III, we summarize 16 articles describing 15 cross-sectional studies evaluating the 
presence of respiratory symptoms, respiratory diagnoses, or airflow limitation among 
workers exposed to styrene [Chmielewski and Renke, 1975; Lorimer et al., 1976, 1978; 
Harkonen, 1977; Axelson and Gustavson, 1978; Thiess and Friedheim, 1978; Jedrychowski 
and Fonte, 1984; Robins et al., 1990; Centers for Disease Control and Prevention (CDC), 
1992; Lewin-Kowalik et al., 1994; Tucek et al., 2002; Oner et al., 2004; Sati et al., 2011; 
Helal and Elshafy, 2013; McCague et al., 2015]. Studies of occupational cohorts varied 
considerably in size (range: 17–4,717 workers). Ten studies evaluated both respiratory 
symptoms/diagnoses and spirometry measurements, four spirometry measurements only, 
and one respiratory symptoms/diagnoses only. Twelve studies included a comparison group 
of the general population, unexposed workers, or workers exposed to lower concentrations 
of styrene. Thirteen of 15 studies had at least suggestive evidence of an association between 
styrene exposure and NMRD-related morbidity. One study had strong evidence.
Eleven cross-sectional studies included respiratory symptoms or disease diagnoses. For the 
eight studies with comparison groups, seven reported a higher prevalence of ≥1 respiratory 
symptom or disease diagnosis among exposed workers. Symptoms reported at higher 
prevalence included cough, dyspnea, shortness of breath, wheeze, chest tightness, and 
recurrent lower respiratory symptoms. Diagnoses reported at higher prevalence included 
asthma, chronic bronchitis, and asthma or chronic bronchitis.
Fourteen studies reported spirometry measurements; of these, nine demonstrated airflow 
limitation among workers. Of the 12 studies with a comparison group, eight showed 
evidence of increased airflow limitation in the exposed groups compared with controls.
Mortality Studies
In Table IV, we summarize 25 articles describing 24 mortality studies of 13 occupational 
cohorts with 343–35,443 workers [Frentzel-Beyme et al., 1978; Nicholson et al., 1978; Ott 
et al., 1980; Meinhardt et al., 1982; Bond et al., 1985, 1992; Hodgson and Jones, 1985; 
Okun et al., 1985; Coggon et al., 1987, 2015; Matanoski and Schwartz, 1987; Matanoski et 
al., 1990; Wong, 1990; Cowles et al., 1994; Olsen et al., 1994; Wong et al., 1994; Welp et 
al., 1996; Sathiakumar et al., 1998; Wong and Trent, 1999; Marsh et al., 2001; Burns et al., 
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2003; Macaluso et al., 2004; Ruder et al., 2004; Sathiakumar and Delzell, 2009; Collins et 
al., 2013; Ruder et al., 2016]. Required tenure varied by study from ≥1 day to ≥5 years. Four 
studies required ≥6 months tenure and 13 required ≥1 year. Twelve studies provided at least 
suggestive evidence of an association between styrene exposure and NMRD-related 
mortality. Two studies had strong evidence.
Mortality rates from NMRD for entire cohorts varied considerably. Four studies analyzing 
their entire cohorts indicated excess mortality from NMRD compared with the general 
population (see Supplementary Table SI for a listing of diagnostic codes used). Although OB 
can be misdiagnosed or classified as COPD on death certificates, only nine studies assessed 
COPD mortality (SMR [standardized mortality ratio] range: 0.85–1.35); of these, six studies 
assessing three cohorts reported excess mortality. The highest SMR for COPD was 
described by Ruder et al. [2016] and occurred among a cohort of boat builders in 
Washington State]. In this cohort, the SMR for COPD among workers characterized as 
having potentially high-exposure to styrene with tenure ≥1 year was 2.02 (95%CI, 1.08–
3.46).
Because OB and asthma are short-latency diseases, they can occur in short-tenured workers. 
Thus, peak and perhaps average styrene exposures might be more important in the disease 
process than cumulative exposures. Only four studies analyzing two separate cohorts 
assessed NMRD-mortality among workers with tenure < 1 year, and each indicated excess 
mortality. Wong [1990] investigated mortality for 15,908 reinforced plastics workers with 
tenure ≥6 months and reported the SMR from emphysema in workers with tenure 6 months–
1 year was 1.28, although the results were not statistically significant. A later analysis of the 
same cohort indicated excess mortality for bronchitis, emphysema, and asthma (SMR, 1.96) 
and other NMRD (SMR 1.80) among workers with tenure 6 months–1 year, but again the 
results were not statistically significant [Wong et al., 1994; Wong and Trent, 1999]. Ruder et 
al. [2004] investigated mortality for workers with tenure <1 year and demonstrated an excess 
mortality from pneumoconiosis and other respiratory diseases (SMR, 2.78 [95%CI, 1.20–
5.667]). A later analysis of the same cohort determined the SMRs for respiratory system 
diseases among workers with tenure <1 year with high and low potential styrene exposures, 
respectively, were 1.99 (95%CI, 1.38–2.79) and 1.64 (95%CI, 0.96–2.63) [Ruder et al., 
2016].
Twelve studies found no positive association between styrene exposure and NMRD-related 
mortality. Of these, 10 required worker tenure ≥6 months, 10 did not specifically report 
COPD-related mortality, and nine did not separately assess workers with high-exposure.
Only two mortality studies required worker tenure ≥1 day, assessed workers by level of 
styrene exposure, and reported COPD-related mortality [Welp et al., 1996; Ruder et al., 
2016]. Welp et al. [1996] studied a cohort of 35,443 reinforced plastics workers from 660 
European factories. Workers with increasing time since first styrene exposure were more 
likely to have died from NMRD. Compared with the referents who worked <10 years, the 
relative risk (RR) (95%CI) for mortality from all respiratory diseases for working 10–19 
years was 2.06 (1.20–3.54) and >20 years was 2.50 (1.28–4.89). Workers were also more 
likely to die from pneumonia with increasing average exposure. Compared with referents 
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exposed to <60 ppm, the RR (95%CI) for pneumonia of those exposed to 60–119 ppm was 
2.07 (0.53–8.04), 120–199 ppm was 3.20 (0.79–13.0), and >200 ppm was 6.10 (1.44–25.8). 
No association was found between mortality from bronchitis, emphysema, or asthma and 
time since first exposure, duration of exposure, average exposure, or cumulative exposure. In 
contrast, Ruder et al. [2016] described excess mortality for COPD among boat builders with 
high styrene exposures and tenure <1 year (SMR, 2.60 [95%CI, 1.70–3.81]) and ≥1 year 
2.02 (95%CI, 1.08–3.46).
Discussion
This review found evidence supporting that working in industries using styrene is a potential 
risk factor for NMRD, including: (i) 10 case reports of OB among persons exposed to 
styrene, including one case that occurred in a worker who replaced another worker 
diagnosed with OB, a highly unusual occurrence for a rare pulmonary disease; (ii) eight case 
reports of occupational asthma among workers exposed to styrene, including six with 
abnormal inhalation challenges to styrene; (iii) four cases of chronic dyspnea that occurred 
among workers who had a short-term exposure to high styrene levels in a shared confined 
space; (iv) 13 of 15 cross-sectional studies of workers provided at least suggestive evidence 
of an association between styrene exposure and airflow limitation or NMRD; and (v) six of 
the nine mortality studies analyzing COPD indicated excess COPD-related mortality.
Obliterative Bronchiolitis
Mortality studies focusing on occupational cancer are not optimally designed to assess short-
latency lung diseases, such as OB. The reviewed studies were mostly large, the cohorts were 
often followed for decades, and one-half required tenures ≥1 year. However, workers 
exposed to styrene might be at-risk for OB that occurs insidiously within weeks to months 
after beginning employment, but stabilizes once styrene exposure ends [Kreiss, 2013], thus 
reducing the likelihood of detecting OB-related morbidity using mortality studies of 
cumulative exposures of long-tenured workers followed for decades for long-latency 
diseases. Indeed, eight (80%) of the 10 identified OB cases had respiratory symptom onset 
within ≤12 months of first exposure to styrene. Wong et al. demonstrated a higher SMR 
from other NMRD for workers with tenure <1 year, and Ruder et al. demonstrated a higher 
SMR from pneumoconiosis and other respiratory diseases, and COPD for workers with 
tenures <1 year [Wong, 1990; Wong et al., 1994; Wong and Trent, 1999; Ruder et al., 2004, 
2016]. Moreover, Ruder et al. [2016] found a decreased SMR from respiratory system 
diseases for workers with high exposure when the cohort was limited to those with tenure ≥1 
year (SMR, 1.64 [95%CI, 0.96–2.63]) compared with ≥1 day (SMR, 1.99 [95%CI, 1.38–
2.79]). Additional studies that include short-term high-exposures and short-tenured workers 
are required to better describe the risk of respiratory disease mortality among workers with 
styrene exposure.
An excess of COPD-related mortality was found in six of the nine mortality studies 
assessing COPD mortality. Although Collins et al. [2013] suggested an observed excess of 
COPD-related mortality in a cohort of U.S. reinforced plastics workers was likely because of 
greater tobacco use among those exposed, this hypothesis remains unexamined [Cummings 
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et al., 2014]. The clinical manifestations of OB can be mistaken for those caused by asthma 
or COPD, which can lead to underreporting [CDC, 2013]. The absence of a medical 
diagnostic code for OB also increases the probability that deaths caused by OB were 
classified as COPD. These details raise the likelihood that at least some of the workers with 
causes of death listed as COPD died instead from OB.
A potential for classification of at least some OB cases as COPD among styrene-exposed 
workers is highlighted by Ruder et al. [2016] where the authors demonstrated a higher 
standardized rate ratio (SRR) for COPD between potentially high- and low-exposure styrene 
subcohorts (SRR, 1.76 [95%CI, 0.80–3.92]) than for lung cancer (SRR, 0.77 [95% CI, 0.42–
1.41]), which suggests the additional mortality from COPD in this boatbuilding cohort is not 
easily attributable to smoking. Further investigation of current workers exposed to styrene 
who are diagnosed with COPD is warranted to examine the possibility for misdiagnosed OB.
Cross-sectional studies can provide unreliable estimates of the health of a cohort of workers 
because of the healthy worker effect [Shah, 2009] and likely underestimate the potential 
respiratory morbidity associated with styrene exposure as ill workers likely leave the 
workforce earlier. Studies relying upon chest X-rays and spirometry measurements are 
further limited in their ability to detect workers with OB as neither diagnostic test is a 
sensitive indicator of disease, and pathologically confirmed cases can have obstructive, 
restrictive, or mixed spirometry patterns, or even normal spirometry measurements 
[Markopoulo et al., 2002; Kreiss, 2013; Cummings and Kreiss, 2015]. For example, a study 
of 38 U.S. soldiers returning from Iraq and Afghanistan who had insidious onset of dyspnea 
were found to have constrictive bronchiolitis following thoracoscopic lung biopsies; of 
those, 37 (97%) had normal chest X-rays, 32 (84%) had normal spirometry measurements, 
and only two (5%) had evidence of obstruction on spirometry [King et al., 2011]. Despite 
the lack of sensitivity of cross-sectional studies, over 86% of the studies we evaluated 
provided at least suggestive evidence that styrene was associated with NMRD-related 
morbidity.
Asthma
Similar to other volatile organic compounds [Nurmatov et al., 2015], available evidence 
indicates that styrene is an asthmagen. Six published case reports of asthma demonstrated 
reduced FEV1 following inhalation challenges with styrene among workers who suffered 
respiratory symptoms when exposed to styrene. Additionally, each of the five living asthma 
cases with known outcomes had improved or resolved symptoms after changing jobs and 
eliminating further styrene exposure. Clinical improvement following elimination of styrene 
exposure also makes it less likely these cases had OB, an irreversible lung disease.
The majority of cross-sectional studies provided evidence suggesting that styrene is a 
potential cause of occupational asthma. A cohort of U.S. styrene workers with higher 
exposure levels compared with those who had lower exposures had a higher prevalence of 
wheezing or chest tightness, and airflow obstruction [Lorimer et al., 1976, 1978]. Similarly, 
Polish workers exposed to styrene had a higher than expected prevalence of asthma and 
obstructive syndrome, and exposed non-smokers/ex-smokers were at higher risk of having 
airway obstruction compared with unexposed non-smokers/ex-smokers [Jedrychowski, 
Nett et al. Page 8













1982; Jedrychowski and Fonte, 1984]. Finally, Egyptian plastics workers compared with 
controls had reduced percent predicted FEV1 and FVC, reduced mean FEV1/FVC 
percentage, and a negative correlation between blood styrene concentrations and both 
FEV1/FVC and maximal mid-expiratory flow rates, an indicator of obstruction of the small 
airways (<2 mm internal diameter) [Helal and Elshafy, 2013]. Further investigation of 
styrene as an asthmagen is needed.
Challenges exist in assessing styrene's role in the development of NMRD as workers 
exposed to styrene are often exposed to multiple chemicals (Supplementary Table SII) 
[CDC, 2009]. Multiple chemical exposures likely occurred at all workplaces described in 
this review, but workers at glass reinforced plastics facilities where styrene exposures are 
highest likely were exposed to fewer chemicals than workers at other facilities [International 
Agency for Research on Cancer, 2002]. The possibility exists that styrene is a surrogate 
marker for another chemical exposure that causes an increase in NMRD-related morbidity 
and mortality among workers exposed to styrene. Interactions are also possible, as 
demonstrated by a study in mice showing the presence of biologically inert respirable glass 
fibers enhanced the respiratory toxicity of styrene in causing lower airway damage [Morisset 
et al., 1979]. The interpretation of published data with respect to exposures to styrene and 
other chemicals simultaneously was further complicated as exposures for facilities described 
in the literature reviewed here were often incomplete. Further animal studies would 
contribute to improved knowledge about the contribution of styrene to respiratory toxicity in 
the context of concurrent chemical exposures.
This analysis is subject to several limitations. First, considering the widespread global use of 
styrene across multiple industries, we identified only 25 cases of NMRD associated with 
exposure. However, the relatively small number of recognized cases might also be related to 
an underrecognition of both OB as clinical diagnosis and occupational causes of asthma. 
Second, available cross-sectional studies for review might be biased toward studies reporting 
a positive association between styrene exposure and NMRD-related morbidity and mortality. 
Third, workers described in the case reports, cross-sectional studies, and mortality studies 
were exposed to often unknown or differing concentrations of styrene, had different lengths 
of exposure, and were exposed to multiple chemicals in the workplace, which potentially 
confounds the results of primary analyses. Fourth, this review included mortality studies that 
did not explicitly assess mortality from COPD, which could result in an underestimation of 
OB-related mortality. When COPD is included with other causes of NMRD, the possible 
effect of COPD is diluted by other diagnoses not associated with styrene exposure as 
demonstrated when examining only COPD-related mortality.
In summary, a review of available case reports, cross-sectional studies, and mortality studies 
suggested occupational exposure to styrene is a potential risk factor for NMRD, and related 
morbidity and mortality. This review highlighted the need for higher quality data. Additional 
animal exposure studies using novel humanized rodent models that better mimic human 
physiology would help address remaining questions regarding the development of lung 
disease following inhalational exposure to styrene. Additional studies should also include 
prospective and longitudinal investigations to further describe the risk for respiratory 
morbidity and mortality among short- and long-tenured workers in industries using styrene, 
Nett et al. Page 9













both during and after employment, particularly for those with high styrene exposures. 
Finally, assessing for styrene and other chemical exposures in future epidemiologic studies 
could allow for added clarification of the influence styrene has on respiratory toxicity in 
workers with mixed chemical exposures.
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Flow diagram showing process for inclusion of studies exploring the association between 
occupational styrene exposure and non-malignant respiratory disease.
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Table I
Criteria Used for Evaluating Strength of Evidence for a Positive Association Between 
Styrene Exposure and NMRD-Related Morbidity or Mortality
Strong (+++) Intermediate (++) Suggestive (+)
Cross-sectional studies (1) Inclusion of styrene-exposed 
and comparison groups,a AND
(1) Inclusion of styrene-exposed 
and comparison groups,a AND
(1) Inclusion of styrene-exposed and 
comparison groupsa and non-
statistically significantb higher 
prevalence for ≥1 respiratory symptom 
or ≥1 NMRD, or airflow limitation on 
spirometry, OR
(2) exposure group had statistically 
significantb higher prevalence for 
≥1 respiratory symptom or NMRD, 
AND
(2) exposure group had statistically 
significantb higher prevalence for 
≥1 respiratory symptom or ≥1 
NMRD, or airflow limitation on 
spirometry
(2) no comparison groupa and the 
presence of exposed workers with 
respiratory symptoms or ≥1 NMRD, or 
airflow limitation on spirometry
(3) exposure group had statistically 
significant higher prevalenceb for 
airflow limitation on spirometry
Mortality studies (1) Analysis of workers by level of 
styrene exposure, AND
All workers or a subset of workers 
had statistically significantb higher 
SMR for ≥1 NMRD
All workers or a subset of workers had 
non-statistically significantb higher 
SMR for ≥1 NMRD
(2) workers with high exposure had 
statistically significantb higher 
SMR for ≥1 NMRD
NMRD, non-malignant respiratory disease; SMR, standardized mortality ratio.
a
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